Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza? by Rimmelzwaan, G.F. (Guus) & Osterhaus, A.D.M.E. (Albert)
UTTERWORTH 
EINEMANN 
Comment 
vaccine, Vol. 13, No. 8, pp. 703-705. 1995 
Copyright 0 t995 Elsevier Science Ltd 
Printed in Great Griiin. AH rights reservBd 
oze+r1axIss $10.al+0.00 
Cytotoxic T lymphocyte memory: role in 
cross-protective immunity against 
influenza? 
G.F. Rimmelzwaan and A.D.M.E. Osterhaus 
MHC class I restricted CD8’ 
cytotoxic T lymphocytes (CTL) 
have been shown to play a role in 
the clearance of several virus 
infections and thus in the prevention 
of disease symptoms they may 
causele9. 
Although the induction of 
protective CTL responses directed 
to influenza virus has been the 
subject of several studies (see Table 
I for review), a role of these cells in 
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the protection from subsequent 
inthtenza virus infections is 
controversial. Despite the existence 
of conserved CTL epitopes present 
in e.g. the nucleoprotein (NP)‘“*l‘ 
of influenza virus strains that infect 
humans in subsequent seasons, there 
is apparently little or no protective 
effect mediated by CTLs directed 
against these epitopesi2. For this 
reason it is argued that 
predominantly the presence of virus 
neutralizing (VN) antibodies with 
the relevant specificities for the 
hemaglutinin (HA) and the 
neuraminidase (NA) membrane 
glycoproteins of the actually 
circulating influenza virus strains is 
protective: protection against 
Table 1 Induction of protection through CTL responses by influenza subunit preparations 
infection proved to be correlated 
with VN serum antibody titers, 
induced by natural infection, 
vaccination or passive transfer13. In 
animal models it was demonstrated 
that CTL responses are not a 
requirement for the recovery from 
influenza infections (Eichelberger et 
al., 19!X33; Scherie et al., 1!B234) 
and that vaccination with 
recombinant vaccinia viruses (rVV) 
expressing the NP or other internal 
proteins, resulted in virus-specific 
MHC class I restricted CTL 
responses but did not protect 
against a lethal challenge with 
influenza virus A/PR/8/34 
(HlNl)‘“‘“. However, in some 
cases a protective effect could be 
observed after adoptive transfer of 
CTLs of this specificity’, 16, 17. 
Immunization with rVVs expressing 
the HA or NA proteins led to the 
induction of virus-neutralizing 
antibodies and complete protection 
from challenge infection. 
Furthermore it was shown that in 
/Urn- knockout mice, which lack 
Protein Virus 
Presentation 
form 
Species 
Immune 
response 
demonstrated Protection Reference 
NP X/31 H3N2 
rNP A/PHI8134 Hl Nl 
rNP AlPR/8/34 Hl Nl 
rNP 
rNP 
HA 
NA 
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HA 
HA 
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NP 
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NP 
NP 
H7Nl 
H2N2 
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Adjuvant: none 
Adjuvant: AI(OH,) 
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typhimurium 
DNA 
Vaccinia virus 
Vaccinia virus 
Vaccinia virus 
Vaccinia virus 
Vaccinia virus 
Vaccinia virus-IL-2 
NSl -HA2 fusion 
protein 
Vaccinia virus 
Vaccinia virus 
Vaccinia virus 
Vaccinia virus 
Vaccinia virus 
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ISCOM 
Fowl pox 
Vaccinia virus 
Balb/c mice (H-2d) 
Balb/c, BIO.A (5%) mice 
Balb/c mice 
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(H-2k) mice 
idem 
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CTL 
Th 
Th 
CTL 
VN 
VN 
VN/CTL 
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CTL 
VN 
ND 
Pulmonary CTL 
Pulmonary CTL 
CTL 
CTL 
No CTL 
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Yes 
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No 
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Yes 
No 
No 
No 
No 
No 
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No 
No, reduced 
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titers d7 p.i. 
Wraith ef a/.25 
Tite et a/.” 
Tite et al.” 
Brett et a/.26 
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Ben-Yehuda et a/.*’ 
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Andrew et a/.” 
Andrew et a/” 
Lawson et a/.‘4 
Lawson et a/.‘4 
Stitz et a/.=’ 
Stitz et a/.2s 
Weiss et aLw 
Webster et al.=’ 
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Vaccine 1995 Volume 13 Number 8 703 
Comment 
CD8’ CTL, HA and NA protein 
expressing rVVs induced protection 
that was fully mediated by VN 
serum antibodies. However, it 
should be realized that in most of 
the studies which failed to induce 
protective immunity by mechanisms 
other than VN antibodies, rVVs 
were used as expression system for 
viral proteins like NP. In other 
experiments using purified NP or 
recombinant NP as immunogens, 
either presented as soluble protein 
or by Salmonella typhimurium as a 
vector, protection could be induced. 
With Sulmonellu as an antigen 
delivery system for NP or with 
recombinant NP in Al(OH),, strong 
T helper (Th) cell responses were 
induced. No direct association of 
protection with virus-specific MHC 
class I restricted CTLs was 
demonstrated”. 19, probably since 
antigens presented in this way are 
highly inefficient in entering the 
endogenous pathway of antigen 
processing”“ *’ A mechanism 
underlying this protection may be 
the accelerated induction of VN 
antibodies and CTLs as a result of 
strong T helper cell responses after 
infection with the challenge virus. 
However, since the immunized mice 
in these exeperiments were also 
protected from challenge with an 
influenza B virus, the action of non- 
specific antiviral mechanisms such 
as the production of IFN? could not 
be excluded”. Studies in nude mice 
showed that a rVV coexpressing IL- 
2 along with HA may confer 
protection in mice in the absence of 
T cells and suggested a role for 
specific IgM antibodies, natural 
killer cell activity and IFNy”. 
Recently, alternative systems have 
been explored for the presentation 
of NP to the immune system 
including nucleic acid vaccination: 
plasmid DNA, which encodes a 
foreign protein under control of a 
eukaryotic promotor sequence, was 
directly injected into muscle tissue of 
recipient mice. Inoculation of mice 
with influenza NP encoding DNA, 
resulted in decreased virus titers in 
the lung, inhibited mass loss and 
increased survival rates not only 
after a homologous challenge with 
influenza A/PREY34 (HlNl), but 
also after a heterologous challenge 
with influenza virus A/HK/68 
(H3N2). In parallel experiments 
neither the passive transfer of NP- 
specific antibodies, nor the 
immunization with purified NP 
could confer protection. In the NP- 
DNA inoculated mice, NP-specific 
CTL were demonstrated which were 
absent in mice immunized with the 
purified protein. 
The observation that humans may 
develop influenza upon infection 
with newly emerging virus strains 
and that mice are not protected 
against a virus challenge after 
vaccination with rVV expressing the 
NP protein, in spite of the induction 
of CTL responses, suggests an 
inadequate induction of CTL 
memory. 
Recently it was shown that for the 
induction of protective cytotoxic T 
cell memory towards lymphocytic 
choriomeningitis virus (LCMV) 
infection, the persistence of viral 
antigen was required”. LCMV- 
specific long-term CTL memory was 
only maintained in persistent 
LCMV infection. Vaccination with 
rVVs expressing LCMV proteins 
resulted in a poor CTL memory, 
which correlated with the rVV dose 
and depended on the LCMV protein 
expressed. Adoptive transfer 
experiments with spleen cells from 
immunized mice confirmed that for 
the maintenance of CTL memory 
the presence of viral antigen was 
essential. These findings are in 
contrast to results recently obtained 
in adoptive transfer experiments, 
which were performed with 
irradiative recipient mice 
(Mullbacher, 199435; Hou et ul., 
1 99436), suggesting that thus 
acquired influenza virus specific 
CTL memory can be maintained in 
the absence of antigen. The 
protective effect of these CTLs was, 
however, not studied by challenge 
infection. 
Therefore we speculate that 
antiviral protection mediated by 
memory CTL is short-lived when 
induced by non-persistent infection 
with, for example, influenza virus. 
Similarly, vaccination with rVV 
expressing the relevant influenza 
proteins or live attenuated influenza 
vaccines may only induce short-lived 
CTL responses in the absence of 
persisting antigen. In contrast the 
persistent low level in viva expession 
of NP after inoculation with NP- 
DNA’“, may lead to protective 
immunity mediated by specific 
CTL. 
Therefore it may be expected that 
if indeed the development of future 
influenza vaccines should take 
advantage of the existence of 
conserved CTL epitopes’O. “, 
resulting in the induction of inter- 
and intratypic cross-protection, they 
should be based upon strategies 
leading to the persistent exposure of 
the immune system to the relevant 
viral antigens. 
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